Alpha Tau Medical
Alpha Tau Medical was founded in 2016 and focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.
Since then, preclinical and clinical trials have found the technology to be effective and safe for various indications and anatomic areas.
The findings were published in 16 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.
With our passion for research and humanity, we are striving to enable a cancer treatment that destroys tumors while sparing healthy tissue and save the lives of millions of patients around the world.
“Humanity will draw more good than evil from new discoveries.” Marie Curie
The Alpha Tau Team is inspired by Marie Curie who discovered Radium in 1898. Sharing the value and eagerness to serve humanity, the company believes that only through research and business collaborations, the therapeutic potential of radium for treating cancer can be entirely fulfilled.